Skip to Content

Microart Inc MCRT

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MCRT is trading at a 884% premium.
Price
$0.00
Fair Value
$3.93
Uncertainty
Extreme
1-Star Price
$9.14
5-Star Price
$1.24
Economic Moat
Cbkk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MCRT is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$5,701.41
Volume/Avg
200 / 530

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Microart Inc provides stem cell solutions, the therapeutic applications of Adult stem cells & the development & commercialization of cell-based anti-ageing research and cosmetic products. The company is developing proprietary technology for the treatment of diabetes.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
Website

Valuation

Metric
MCRT
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
MCRT
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
MCRT
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
KbxvkbpmRsmnl$625.5 Bil
Vertex Pharmaceuticals Inc
VRTX
MxzbmrsyjMyrygl$127.0 Bil
Regeneron Pharmaceuticals Inc
REGN
NqgszrxbRckvlq$119.0 Bil
Moderna Inc
MRNA
JkthjngMhjhj$47.1 Bil
Alnylam Pharmaceuticals Inc
ALNY
XkqctjykwWfpstqr$33.0 Bil
argenx SE ADR
ARGX
MvmypdqlzXdty$27.7 Bil
BioNTech SE ADR
BNTX
PnfcyhxmmWrdx$20.4 Bil
Biomarin Pharmaceutical Inc
BMRN
XzmbynqfLyflbc$15.9 Bil
United Therapeutics Corp
UTHR
VpqsgcvqMpp$14.4 Bil
Incyte Corp
INCY
XsjlmxdhPkfnyf$12.3 Bil

Sponsor Center